Advanced Health Past Earnings Performance

Past criteria checks 0/6

Advanced Health has been growing earnings at an average annual rate of 0.5%, while the Healthcare industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 10% per year.

Key information

0.5%

Earnings growth rate

7.7%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate10.0%
Return on equity5.1%
Net Margin-3.1%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

Investors Will Want Advanced Health's (JSE:AVL) Growth In ROCE To Persist

Jun 10
Investors Will Want Advanced Health's (JSE:AVL) Growth In ROCE To Persist

Is Advanced Health (JSE:AVL) A Risky Investment?

Apr 18
Is Advanced Health (JSE:AVL) A Risky Investment?

Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Jan 31
Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Auditors Have Doubts About Advanced Health (JSE:AVL)

Oct 14
Auditors Have Doubts About Advanced Health (JSE:AVL)

Returns At Advanced Health (JSE:AVL) Are On The Way Up

Jun 29
Returns At Advanced Health (JSE:AVL) Are On The Way Up

The Return Trends At Advanced Health (JSE:AVL) Look Promising

Mar 16
The Return Trends At Advanced Health (JSE:AVL) Look Promising

Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Sep 02
Advanced Health's (JSE:AVL) Returns On Capital Are Heading Higher

Does Advanced Health (JSE:AVL) Have A Healthy Balance Sheet?

Jun 26
Does Advanced Health (JSE:AVL) Have A Healthy Balance Sheet?

Here's What To Make Of Advanced Health's (JSE:AVL) Decelerating Rates Of Return

Apr 28
Here's What To Make Of Advanced Health's (JSE:AVL) Decelerating Rates Of Return

Read This Before Selling Advanced Health Limited (JSE:AVL) Shares

Feb 28
Read This Before Selling Advanced Health Limited (JSE:AVL) Shares

Revenue & Expenses Breakdown

How Advanced Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

JSE:AVL Revenue, expenses and earnings (ZAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 22687-2170
30 Sep 22676-2170
30 Jun 22665-2070
31 Mar 22446-4480
31 Dec 21445-4590
30 Sep 21563-3780
30 Jun 21681-2880
31 Mar 21618-8060
31 Dec 20554-13340
30 Sep 20515-14040
30 Jun 20476-14740
31 Dec 19499-3200
30 Sep 19491-3100
30 Jun 19482-3100
31 Dec 18451-2920
30 Sep 18429-3120
30 Jun 18407-3420
31 Mar 18384-4420
31 Dec 17359-4820
30 Sep 17334-4820
30 Jun 17309-4820
31 Mar 17298-4520
31 Dec 16287-4320
30 Sep 16264-3020
30 Jun 16241-1820
31 Mar 16216-3310
31 Dec 1519113610
30 Sep 1518615610
30 Jun 1518017610
31 Mar 1517713530
31 Dec 141749450
30 Sep 141658450
30 Jun 141568450
30 Jun 131269450

Quality Earnings: AVL is currently unprofitable.

Growing Profit Margin: AVL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AVL is unprofitable, but has reduced losses over the past 5 years at a rate of 0.5% per year.

Accelerating Growth: Unable to compare AVL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AVL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.7%).


Return on Equity

High ROE: AVL has a negative Return on Equity (5.11%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/29 04:56
End of Day Share Price 2023/09/19 00:00
Earnings2022/12/31
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Advanced Health Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pui LiMacquarie Research